Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Expert Review of Neurotherapeutics|June 4, 2015
Apomorphine hydrochloride for the treatment of Parkinson's diseaseElisa Unti, Roberto Ceravolo, Ubaldo BonuccelliNeurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 2, 2023
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndromeElisabetta Belli, Eleonora Del Prete, Elisa Unti, et al.BMC Neurology|August 26, 2021
Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-CGabriele Bellini, Eleonora Del Prete, Elisa Unti, et al.Brain and Behavior|May 11, 2019
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndromeElisa Unti, Sonia Mazzucchi, Rosanna Calabrese, et al.Neurorehabilitation|May 17, 2017
Efficacy of a combined therapeutic approach in the management of Pisa SyndromeSiria Di Martino, Elisa Unti, Caterina Tramonti, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 12, 2020
Theory of mind in Parkinson's disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapyEleonora Del Prete, Pierpaolo Turcano, Elisa Unti, et al.Restorative Neurology and Neuroscience|February 15, 2018
Aerobic rehabilitation program for improving muscle function in Parkinson's diseaseSiria Di Martino, Caterina Tramonti, Elisa Unti, et al.Parkinsonism & Related Disorders|June 18, 2013
Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT studyLorenzo Kiferle, Sonia Mazzucchi, Elisa Unti, et al.Brain Sciences|August 29, 2018
Social Cognition and Oxytocin in Huntington's Disease: New InsightsElisa Unti, Sonia Mazzucchi, Daniela Frosini, et al.Toxicology|October 28, 2009
The hOGG1 Ser326Cys polymorphism and Huntington's diseaseFabio Coppedè, Francesca Migheli, Roberto Ceravolo, et al.Pageof 2